ATC Group: A07AA02 Nystatin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07AA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3 A07A Intestinal antiinfectives
4 A07AA Antibiotics
5 A07AA02 Nystatin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1,500,000 [iU]

Active ingredients in A07AA02

Active Ingredient Description
Nystatin

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

Related product monographs

Title Information Source Document Type  
MYCOSTATIN Oral suspension Health Products Regulatory Authority (IE) MPI, EU: SmPC
RESTATIN Coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

New Zealand (NZ)

Poland (PL)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.